Finance
GSK’s Overhaul Undermined by Decline From Older Medicines
GSK Plc’s older respiratory medicines showed lackluster sales in the first quarter, leaving HIV and cancer drugs to drive profit growth.
B
Bloomberg
April 29, 2026·1 min read
Image: Bloomberg
GSK Plc’s older respiratory medicines showed lackluster sales in the first quarter, leaving HIV and cancer drugs to drive profit growth.
Original article
GSK’s Overhaul Undermined by Decline From Older Medicines
Published by Bloomberg